about
BMI and BMD: The Potential Interplay between Obesity and Bone FragilityThe alliance of mesenchymal stem cells, bone, and diabetesMechanisms of diabetes mellitus-induced bone fragility.Unexpectedly high rates of obesity and dysglycemia among villagers in Cameroon.Quality of diet and potential renal acid load as risk factors for reduced bone density in elderly womenSerum 25-OH Vitamin D in relation to Bone Mineral Density and Bone Turnover.High prevalence of low vitamin D and musculoskeletal complaints in women with breast cancer.No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes: the IMDIAB XIII trial.Effect of weight loss, exercise, or both on cognition and quality of life in obese older adultsIncreasing adiposity is associated with higher adipokine levels and lower bone mineral density in obese older adultsFat, muscle, and bone interactions in obesity and the metabolic syndromeIncreased carotid thickness in subjects with recently-diagnosed diabetes from rural Cameroon.Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group ReportA new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats.Circulating sclerostin associated with vertebral bone marrow fat in older men but not womenWeight loss, exercise, or both and physical function in obese older adults.Increased 2-hydroxylation of estrogen is associated with lower body fat and increased lean body mass in postmenopausal women.Fracture risk in diabetic elderly men: the MrOS study.Exercise training in obese older adults prevents increase in bone turnover and attenuates decrease in hip bone mineral density induced by weight loss despite decline in bone-active hormones.Genetic polymorphism at Val80 (rs700518) of the CYP19A1 gene is associated with body composition changes in women on aromatase inhibitors for ER (+) breast cancer.Weight loss in obese older adults increases serum sclerostin and impairs hip geometry but both are prevented by exercise training.Are women with thicker cortices in the femoral shaft at higher risk of subtrochanteric/diaphyseal fractures? The study of osteoporotic fractures.Adiponectin and bone mass density: The InCHIANTI studyDifferential effect of zoledronic acid on normal trabecular and cortical bone density in oncologic patients with bone metastases.Risk factors for subtrochanteric and diaphyseal fractures: the study of osteoporotic fracturesEffect of calcitriol on bone turnover and osteocalcin in recent-onset type 1 diabetes.Effects of polymorphisms of the sex hormone-binding globulin (SHBG) gene on free estradiol and bone mineral density.The FTO gene is associated with a paradoxically favorable cardiometabolic risk profile in frail, obese older adultsFracture Rate, Quality of Life and Back Pain in Patients with Osteoporosis Treated with Teriparatide: 24-Month Results from the Extended Forsteo Observational Study (ExFOS).The association between a functional CYP1A1 polymorphism and colorectal neoplasia risk in post menopausal women.Weight loss, exercise or both and cardiometabolic risk factors in obese older adults: results of a randomized controlled trial.Bone turnover markers: understanding their value in clinical trials and clinical practice.Bone health as a function of adipokines and vitamin D pattern in elderly patients.Effect of ghrelin on bone mass density: the InChianti studyChanges in thigh muscle volume predict bone mineral density response to lifestyle therapy in frail, obese older adultsDenosumab: the era of targeted therapies in bone metastatic diseases.The Val432Leu polymorphism of the CYP1B1 gene is associated with differences in estrogen metabolism and bone density.Genetic polymorphism at Val80 (rs700518) of the CYP19A1 gene is associated with aromatase inhibitor associated bone loss in women with ER + breast cancer.Serum 25-hydroxyvitamin D concentration does not independently predict incident diabetes in older women.A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis.
P50
Q26744811-9FF058D7-F8C3-4040-9327-73A5A0AA8940Q27012497-CF494387-5E66-42CA-885A-91B94B60CA00Q30241947-DA5C9AB2-151D-429A-A14F-6EB2BABB0995Q30384844-338C7BBF-1F84-41D4-8A8D-95190F144285Q33896576-2D485C09-79DA-4164-998F-1C3B973EB396Q33993043-C4B22D95-B189-4E47-B59B-3CDCE79007B6Q34024686-30DF7A1B-99D8-4A1E-9B20-062162074F44Q34084512-B0612C4C-B6A2-4ED9-B91E-A4D87A15BA4AQ34087171-E012DBD7-8E39-49C7-BBC2-D8D82ED8DB2FQ34131007-6181BFDE-7424-42EF-A360-A6158CEFF935Q34274769-7CFA04F3-3CAE-41EA-829A-7344CF6BBFDBQ34390728-9B73F9B7-120A-4907-926A-3D196FEADBAAQ34486831-01CF7AEC-4EE2-4687-90BD-A1CBD09DBBF8Q34562656-6B7AF65B-B4A0-4560-89DB-84C7D24FFF32Q34628276-7FCA6579-11CA-4FE8-B00A-471D308C5FDAQ35044094-F81F4BB4-C83E-484F-B858-20BE91CCC858Q35064178-FAE3187C-1B9F-4B1A-B910-3AECA019C4D5Q35130554-73FF70B0-211F-4425-914A-854D3D20730AQ35510694-239D3A8A-B039-4B90-936F-6087A4E7F289Q35842073-00396551-CDD7-4352-BB71-4C3D3456BB8CQ35992294-00CE68B2-E432-43FE-8ADF-B1CF6991F4A7Q36069758-4C5782CE-4BCB-4EBA-8AF1-9AFEC018D473Q36215679-407B1F1E-98BC-4DF1-A760-83C4283A1E1FQ36491383-C739A2B3-1BF6-494B-8A96-12C04BD302DAQ36589370-652A87CF-A96B-46E5-A10C-FE89DD4FF812Q36625037-3509BFBB-7313-4296-8CFA-298F17E0CF3DQ36947048-6B7D5491-AB06-4556-AB41-D63BFD90EEB2Q37033925-1059E675-4CAA-4C95-B5DC-F5D2C6BD5495Q37124509-2D45C9DB-4A4B-4DC4-8C06-9E0439517EF6Q37254723-3F618DA6-DAFE-4F3D-83BB-718011D0775DQ37330255-BC89AFC4-C501-4EBC-A284-290AF6C9E565Q37384765-5B474E31-0E99-404A-8E26-94C918D075C9Q37406678-15CEB77E-EB13-4239-8862-DCFBD20CFAF3Q37429006-2B575852-2041-48EC-BC9E-BC84B6457740Q37521197-999371B6-654C-4D16-9217-143F1386E19CQ37660431-B3A07862-F58E-49BB-8394-13C20B694A54Q37665507-BB857F75-1CF1-4E63-A2E9-B17929F36D46Q37665513-D5807140-00DC-4556-9050-AA1D2D3C7BD6Q37705163-2F3B05C1-AD03-480A-8900-B1738BC6A25BQ37995500-4FEEA0E4-0678-40EE-A683-29BEFFFCB3B0
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Nicola Napoli
@ast
Nicola Napoli
@en
Nicola Napoli
@es
Nicola Napoli
@nl
Nicola Napoli
@sl
type
label
Nicola Napoli
@ast
Nicola Napoli
@en
Nicola Napoli
@es
Nicola Napoli
@nl
Nicola Napoli
@sl
prefLabel
Nicola Napoli
@ast
Nicola Napoli
@en
Nicola Napoli
@es
Nicola Napoli
@nl
Nicola Napoli
@sl
P1053
K-8242-2016
P106
P1153
35518565500
P21
P31
P3829
P496
0000-0002-3091-8205